Top advances of the year: Hepatobiliary cancers.

Published in: Cancer (2023)

This commentary reviews top advances in hepatobiliary cancer research in 2021-2022, focusing on leveraging immunotherapeutics in combination with other therapies earlier in the disease course and targeted to patient's individualized biomarkers that may predict response or resistance to checkpoint inhibitors.

Keyphrases

papillary thyroid
dna damage
case report
squamous cell
cell cycle
childhood cancer
cancer therapy
squamous cell carcinoma
systematic review
lymph node metastasis
randomized controlled trial
cell proliferation